View Clinical Trial (Medical Research Study)
Investigational Anti-HIV Drug - Burbank CA (Clinical Trial 8553) (Clinical Trial 8553)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.
|
 |
 |
| City: |
|
Burbank |
| State: |
|
CA |
| Zip Code: |
|
91505 |
| Study summary: |
|
This is a double-blind, placebo-controlled, dose escalation study of KD-247 in asymptomatic HIV-1 seropositive subjects who do not currently need antiretroviral therapy. Eligible subjects will be randomized to 1 of 3 cohorts and will receive 3 infusions of 4, 8 or 16 mg/kg of KD-247 or placebo over a 2-week period. A maximum of 9 active subjects and 3 placebo subjects will be allowed per cohort. Study duration is approximately 4 months (including up to 8 weeks, but not less than 3 weeks between screening and baseline, plus a 12-16 week follow-up period after the final infusion of study drug.) |
| Qualified participants must: |
|
• Be 18-64 years of age
•
Have HIV viral load between 1000 and 100,000copies/mL
•
Have CD4 cell count of >350 cells/mm
•
Be treatment naive, or off antiretroviral drugs for at least 8 weeks prior to screening
•
Have a viral genotype sequence that conforms with the principal neutralizing determinant of KD-247 (will be determined by genotype testing)
|
| Participants will receive: |
|
Physical Exam, all lab and blood work, ECG, possible financial compensation for time and travel up to $100 a visit. |
|
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.